| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |